Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Immunity|April 16, 2017
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established TumorsFrederick Arce Vargas, Andrew J S Furness, Isabelle Solomon, et al.
Cancer Discovery|January 8, 2025
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx RenalÁngel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Cancer Cell|March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 AntibodiesFrederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
Nature Ecology & Evolution|December 24, 2021
Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal studyXiao Fu, Yue Zhao, Jose I Lopez, et al.
Nature Medicine|May 27, 2021
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2Lewis Au, Annika Fendler, Scott T C Shepherd, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2024
The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effectsCarolin Ertl, Theresa Ruf, Dirk Mentzer, et al.
Nature Medicine|June 5, 2020
Publisher Correction: Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancerKroopa Joshi, Marc Robert de Massy, Mazlina Ismail, et al.
Nature Medicine|October 9, 2019
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancerKroopa Joshi, Marc Robert de Massy, Mazlina Ismail, et al.
Science (New York, N.Y.)|March 5, 2016
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockadeNicholas McGranahan, Andrew J S Furness, Rachel Rosenthal, et al.
Pageof 5